Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for modulating MECP2 expression

Compositions and methods for modulating MECP2 expression

US Patent 10655128 · Granted May 19, 2020

Estimated economic value: $22,813,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Muscle targeting complexes and uses thereof for treating myotonic dystrophy2025
United states2025
Complexes comprising an anti-transferrin receptor antibody linked to an oligonuc2025
Muscle targeting complexes and formulations for treating myotonic dystrophy2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies2025
Complexes comprising an anti-transferrin receptor antibody linked to an oligonic2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies2025
Complexes comprising an anti-transferrin receptor antibody linked to an oligonuc2025
Muscle-targeting complexes comprising an anti-transferin receptor antibody linke2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies2025
Muscle targeting complexes comprising an anti-transferrin receptor antibody link2025